Design principles for orally bioavailable drugs

被引:162
作者
Navia, MA
Chaturvedi, PR
机构
[1] Vertex Pharmaceuticals Inc., Cambridge, MA 02139-4211
关键词
D O I
10.1016/1359-6446(96)10020-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Compound design is the hallmark of modern pharmaceutical research and development. Unfortunately, comprehensive and reliable guidelines for the introduction of favorable bioavailability properties into designed compounds remain elusive. Here, the authors discuss the limited set of design principles that address the problem of bioavailability, based on a retrospective analysis of orally bioavailable drugs. The roles of partition coefficient, molecular weight, carrier-mediated transport and conformational flexibility are evaluated. These properties are discussed as guiding principles only, and cannot be considered ail-encompassing determinants of oral bioavailability.
引用
收藏
页码:179 / 189
页数:11
相关论文
共 57 条
[1]   ESTIMATING HUMAN ORAL FRACTION DOSE ABSORBED - A CORRELATION USING RAT INTESTINAL-MEMBRANE PERMEABILITY FOR PASSIVE AND CARRIER-MEDIATED COMPOUNDS [J].
AMIDON, GL ;
SINKO, PJ ;
FLEISHER, D .
PHARMACEUTICAL RESEARCH, 1988, 5 (10) :651-654
[2]  
AMIDON GL, 1994, ANNU REV PHARMACOL, V34, P321
[3]  
[Anonymous], CURR OPIN STRUCT BIO
[4]   THIENOTHIOPYRAN-2-SULFONAMIDES - NOVEL TOPICALLY ACTIVE CARBONIC-ANHYDRASE INHIBITORS FOR THE TREATMENT OF GLAUCOMA [J].
BALDWIN, JJ ;
PONTICELLO, GS ;
ANDERSON, PS ;
CHRISTY, ME ;
MURCKO, MA ;
RANDALL, WC ;
SCHWAM, H ;
SUGRUE, MF ;
SPRINGER, JP ;
GAUTHERON, P ;
GROVE, J ;
MALLORGA, P ;
VIADER, MP ;
MCKEEVER, BM ;
NAVIA, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (12) :2510-2513
[5]  
BANNER DW, 1991, J BIOL CHEM, V266, P20085
[6]   THE DESIGN OF PEPTIDE ANALOGS FOR IMPROVED ABSORPTION [J].
BARLOW, D ;
SATOH, T .
JOURNAL OF CONTROLLED RELEASE, 1994, 29 (03) :283-291
[7]   3-DIMENSIONAL STRUCTURE AND ACTIONS OF IMMUNOSUPPRESSANTS AND THEIR IMMUNOPHILINS [J].
BRAUN, W ;
KALLEN, J ;
MIKOL, V ;
WALKINSHAW, MD ;
WUTHRICH, K .
FASEB JOURNAL, 1995, 9 (01) :63-72
[8]   THE INFLUENCE OF PEPTIDE STRUCTURE ON TRANSPORT ACROSS CACO-2 CELLS [J].
CONRADI, RA ;
HILGERS, AR ;
HO, NFH ;
BURTON, PS .
PHARMACEUTICAL RESEARCH, 1991, 8 (12) :1453-1460
[9]   EXPRESSION CLONING OF A MAMMALIAN PROTON-COUPLED OLIGOPEPTIDE TRANSPORTER [J].
FEI, YJ ;
KANAI, Y ;
NUSSBERGER, S ;
GANAPATHY, V ;
LEIBACH, FH ;
ROMERO, MF ;
SINGH, SK ;
BORON, WF ;
HEDIGER, MA .
NATURE, 1994, 368 (6471) :563-566
[10]   PASSIVE AND CARRIER-MEDIATED INTESTINAL-ABSORPTION COMPONENTS OF 2 ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR PRODRUGS IN RATS - ENALAPRIL AND FOSINOPRIL [J].
FRIEDMAN, DI ;
AMIDON, GL .
PHARMACEUTICAL RESEARCH, 1989, 6 (12) :1043-1047